Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer, May 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 384 articles:
HTML format


 

Single Articles

  1. ASLAN V, Sutcuoglu O, Ozet A, Ozdemir N, et al
    Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer.
    J Clin Oncol. 2022 Apr 29:JCO2200084. doi: 10.1200/JCO.22.00084.
    PubMed    


  2. MENG H, Miao S, Teng P
    Cardiac Metastasis of Cervical Cancer: A Case Report and Review of The Literature.
    Heart Surg Forum. 2022;25:E326-E329.
    PubMed    
    Abstract available

  3. DATKHILE KD, Durgawale PP, Patil MN, Gudur RA, et al
    Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
    Asian Pac J Cancer Prev. 2022;23:1291-1300.
    PubMed    
    Abstract available

  4. SONG L, Liu S, Zhao S
    Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target
    Bioengineered. 2022;13:11240-11257.
    PubMed    
    Abstract available


  5. [Factors associated with access barriers to cervical cancer screening in Yaounde].
    Sante Publique. 2021;Vol.
    PubMed    
    Abstract available

  6. LEE JS, Wasim AM, Karreman E, Al-Hayki M, et al
    Hormone therapy use among young cervical cancer patients in Southern Saskatchewan.
    J Obstet Gynaecol Can. 2022 Apr 25. pii: S1701-2163(22)00332.
    PubMed    
    Abstract available

  7. RAZLOG R, Kruger CA, Abrahamse H
    Enhancement of Conventional and Photodynamic Therapy for Treatment of Cervical Cancer with Cannabidiol.
    Integr Cancer Ther. 2022;21:15347354221092706.
    PubMed    
    Abstract available

  8. ALAM Z, Dean JA, Janda M
    What do South Asian immigrant women know about HPV, cervical cancer and its early detection: A cross-sectional Australian study.
    J Migr Health. 2022;5:100102.
    PubMed    
    Abstract available

  9. ZONG J, You M, Li C
    Effect of Kegel Pelvic Floor Muscle Exercise Combined with Clean Intermittent Self-catheterization on urinary retention after radical hysterectomy for cervical cancer.
    Pak J Med Sci. 2022;38.
    PubMed    
    Abstract available

  10. OMEKE CA, Enebe JT, Ugwu AI, Onyishi NT, et al
    The magnitude and predictors of cervical squamous intraepithelial lesions among women in Enugu, Nigeria: a cross-sectional study of women in a low-resource setting.
    Pan Afr Med J. 2022;41:130.
    PubMed    
    Abstract available

  11. YAO Y, Liang Y, Dong X, Liu S, et al
    Association of Long Non-Coding RNAs (lncRNAs) ANRIL and MALAT1 Polymorphism with Cervical Cancer.
    Pharmgenomics Pers Med. 2022;15:359-375.
    PubMed    
    Abstract available

  12. CHEN S, Zhu L, Du Z, Ma R, et al
    Polymer encapsulated clinical ICG nanoparticles for enhanced photothermal therapy and NIR fluorescence imaging in cervical cancer.
    RSC Adv. 2021;11:20850-20858.
    PubMed    
    Abstract available

  13. RAVINDER D, Rampogu S, Dharmapuri G, Pasha A, et al
    Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approaches.
    Med Oncol. 2022;39:61.
    PubMed    
    Abstract available

  14. SUN HN, Xie DP, Ren CX, Guo XY, et al
    Ethyl beta-Carboline-3-Carboxylate Increases Cervical Cancer Cell Apoptosis Through ROS-p38 MAPK Signaling Pathway.
    In Vivo. 2022;36:1178-1187.
    PubMed    
    Abstract available

  15. WANG X, Meng W, Zhang L, He M, et al
    The "Hand as Foot" teaching method in the cervical cancer.
    Asian J Surg. 2022 Apr 24. pii: S1015-9584(22)00415.
    PubMed    


  16. YAO T, Yao Y, Chen Z, Peng Y, et al
    CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance.
    Cancer Cell Int. 2022;22:165.
    PubMed    
    Abstract available

  17. ZHANG D, Song J, Zhang X, Bi H, et al
    The value of p16(INK4a) immunostaining for high-grade squamous intraepithelial lesions in human papillomavirus-negative patients.
    BMC Womens Health. 2022;22:138.
    PubMed    
    Abstract available

  18. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and cervical cancer: Correspondence.
    Wien Med Wochenschr. 2022 Apr 27. pii: 10.1007/s10354-022-00932.
    PubMed    


  19. BAABU PRS, Srinivasan S, Nagarajan S, Muthamilselvan S, et al
    End-to-end computational approach to the design of RNA biosensors for detecting miRNA biomarkers of cervical cancer.
    Synth Syst Biotechnol. 2022;7:802-814.
    PubMed    
    Abstract available

  20. MURAKAMI N, Watanabe M, Uno T, Sekii S, et al
    Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical
    Jpn J Clin Oncol. 2022 Apr 25. pii: 6573954. doi: 10.1093.
    PubMed    
    Abstract available

  21. NNAJI CA, Kuodi P, Walter FM, Moodley J, et al
    Effectiveness of interventions for improving timely diagnosis of breast and cervical cancers in low-income and middle-income countries: a systematic review.
    BMJ Open. 2022;12:e054501.
    PubMed    
    Abstract available

  22. GRABENBAUER GG, Trofymov A
    [Late toxicity after adjuvant radiotherapy for cervical cancer-comparison of conventional radiation therapy with image-guided intensity-modulated radiotherapy].
    Strahlenther Onkol. 2022 Apr 25. pii: 10.1007/s00066-022-01935.
    PubMed    


  23. O'LEARY K
    Single vaccine shot protects against cervical cancer.
    Nat Med. 2022 Apr 25. pii: 10.1038/d41591-022-00056.
    PubMed    


  24. MORALE MG, Tamura RE, Cintra R, Araujo NM, et al
    TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line.
    Sci Rep. 2022;12:6714.
    PubMed    
    Abstract available

  25. FENG S, Ge Y, Ma X, Zhang K, et al
    The genomic landscape of invasive stratified mucin-producing carcinoma of the uterine cervix: the first description based on whole-exome sequencing.
    J Transl Med. 2022;20:187.
    PubMed    


  26. PERERA KC, Mapitigama KN, Abeysena TC
    Acceptability, simplicity, and relevance of the new human papillomavirus/DNA test among 35-year-old ever-married women in a district of Sri Lanka: focus group discussions.
    BMC Womens Health. 2022;22:131.
    PubMed    
    Abstract available

  27. ZHU Y, Zhou J, Zhu L, Hu W, et al
    Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer.
    Hum Vaccin Immunother. 2022 Apr 25:1-11. doi: 10.1080/21645515.2022.2060019.
    PubMed    
    Abstract available

  28. SARAIYA M, Colbert J, Bhat GL, Almonte R, et al
    Computable Guidelines and Clinical Decision Support for Cervical Cancer Screening and Management to Improve Outcomes and Health Equity.
    J Womens Health (Larchmt). 2022;31:462-468.
    PubMed    
    Abstract available

  29. SIDHU H, Gautam LK, Capalash N
    Unraveling the molecular mechanism of l-menthol against cervical cancer based on network pharmacology, molecular docking and in vitro analysis.
    Mol Divers. 2022 Apr 25. pii: 10.1007/s11030-022-10429.
    PubMed    
    Abstract available

  30. SRAVANI AB, Ghate V, Lewis S
    Human papillomavirus infection, cervical cancer and the less explored role of trace elements.
    Biol Trace Elem Res. 2022 Apr 25. pii: 10.1007/s12011-022-03226.
    PubMed    
    Abstract available

  31. ZHOU X, Zhao X, Wu Z, Ma Y, et al
    LncRNA FLVCR1-AS1 mediates miR-23a-5p/SLC7A11 axis to promote malignant behavior of cervical cancer cells.
    Bioengineered. 2022;13:10454-10466.
    PubMed    
    Abstract available

  32. PURBADI S, Novianti L, Tanamas G, Siregar TP, et al
    Comparison of Magnetic Resonance Imaging and Ultrasonography in Tumor Size: Evaluation of Equality in Advanced Cervical Cancer Patients.
    J Med Ultrasound. 2021;30:41-44.
    PubMed    
    Abstract available

  33. CHEN H, Xie H, Wang P, Yan S, et al
    A 25 Immune-Related Gene Pair Signature Predicts Overall Survival in Cervical Cancer.
    Cancer Inform. 2022;21:11769351221090921.
    PubMed    
    Abstract available

  34. ZHANG H, Jin S, Ji A, Zhang C, et al
    Correlation between Vaginal Microecological Status and Prognosis of CIN Patients with High-Risk HPV Infection.
    Biomed Res Int. 2022;2022:3620232.
    PubMed    
    Abstract available

  35. ANIPINDI M, Smith RJ, Gilani M
    Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer.
    Front Oncol. 2022;12:856944.
    PubMed    
    Abstract available

  36. SMITH DL, Perkins RB
    Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic.
    Prev Med. 2022 Apr 21:107070. doi: 10.1016/j.ypmed.2022.107070.
    PubMed    
    Abstract available

  37. BURMEISTER CA, Khan SF, Schafer G, Mbatani N, et al
    Cervical cancer therapies: current challenges and future perspectives.
    Tumour Virus Res. 2022 Apr 20:200238. doi: 10.1016/j.tvr.2022.200238.
    PubMed    
    Abstract available

  38. URBUTE A, Kjaer SK, Kesmodel US, Frederiksen K, et al
    Women with obesity participate less in cervical cancer screening and are more likely to have unsatisfactory smears: Results from a nationwide Danish cohort study.
    Prev Med. 2022;159:107072.
    PubMed    
    Abstract available

  39. HARPER DM, Tariq M, Alhawli A, Syed N, et al
    Comparative predictors for cervical cancer screening in Southeast Michigan for Middle Eastern-North African (MENA), White and African American/black women.
    Prev Med. 2022 Apr 20:107054. doi: 10.1016/j.ypmed.2022.107054.
    PubMed    
    Abstract available

  40. DATTA GD, Pana MP, Mayrand MH, Glenn B, et al
    Racial/ethnic inequalities in cervical cancer screening in the United States: An outcome reclassification to better inform interventions and benchmarks.
    Prev Med. 2022 Apr 20:107055. doi: 10.1016/j.ypmed.2022.107055.
    PubMed    
    Abstract available

  41. XU X, Zhang Y, Yu L, Shi X, et al
    A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women.
    Sci Rep. 2022;12:6609.
    PubMed    
    Abstract available

  42. PECHACOVA Z, Lohynska R, Weitoschova Z, Zikan M, et al
    Chemoradiotherapy in the treatment of cervical cancer - a single institution retrospective review.
    Klin Onkol. 2022;35:139-149.
    PubMed    
    Abstract available

  43. YANG Z, Zhang C, Luo P, Ye M, et al
    Genetic variability of E6 and E7 genes of human papillomavirus type 58 in Jingzhou, Hubei Province of central China.
    Virol J. 2022;19:71.
    PubMed    
    Abstract available

  44. ZHANG J, Guo ZY, Shao CL, Zhang XQ, et al
    Nigrosporins B, a Potential Anti-Cervical Cancer Agent, Induces Apoptosis and Protective Autophagy in Human Cervical Cancer Ca Ski Cells Mediated by PI3K/AKT/mTOR Signaling Pathway.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  45. HAMPSON IN
    Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology.
    Viruses. 2022;14.
    PubMed    
    Abstract available

  46. VEGA CRESPO B, Neira VA, Ortiz Segarra J, Rengel RM, et al
    Role of Self-Sampling for Cervical Cancer Screening: Diagnostic Test Properties of Three Tests for the Diagnosis of HPV in Rural Communities of Cuenca, Ecuador.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  47. LAGUNAS-MARTINEZ A, Madrid-Marina V, Gomez-Ceron C, Deas J, et al
    The Autophagy Process in Cervical Carcinogenesis: Role of Non-Coding-RNAs, Molecular Mechanisms, and Therapeutic Targets.
    Cells. 2022;11.
    PubMed    
    Abstract available

  48. POPESCU A, Craina M, Pantea S, Pirvu C, et al
    COVID-19 Pandemic Impact on Surgical Treatment Methods for Early-Stage Cervical Cancer: A Population-Based Study in Romania.
    Healthcare (Basel). 2022;10.
    PubMed    
    Abstract available

  49. DOLCIAMI M, Capuani S, Celli V, Maiuro A, et al
    Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  50. DIAZ-FEIJOO B, Acosta U, Torne A, Gil-Ibanez B, et al
    Surgical Outcomes of Laparoscopic Pelvic Lymph Node Debulking during Staging Aortic Lymphadenectomy in Locally Advanced Cervical Cancer: A Multicenter Study.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  51. WANG S, Wang Y, Liu X, Yang Y, et al
    SFN Enhanced the Radiosensitivity of Cervical Cancer Cells via Activating LATS2 and Blocking Rad51/MDC1 Recruitment to DNA Damage Site.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  52. VASILEVSKA D, Vasilevska D, Semczuk A, Rudaitis V, et al
    Retrospective Comparison of Laparoscopic versus Open Radical Hysterectomy for Early-Stage Cervical Cancer in a Single Tertiary Care Institution from Lithuania between 2009 and 2019.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  53. TOSIC GOLUBOVIC S, Binic I, Krtinic D, Djordjevic V, et al
    Risk Factors and Predictive Value of Depression and Anxiety in Cervical Cancer Patients.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  54. POPESCU A, Craina M, Pantea S, Pirvu C, et al
    COVID-19 Pandemic Effects on Cervical Cancer Diagnosis and Management: A Population-Based Study in Romania.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  55. EBSTEIN D, Vu F, Bodenmann P, De Valliere S, et al
    [Management of human papillomavirus at the doctor's office : what to do for men ?]
    Rev Med Suisse. 2022;18:770-773.
    PubMed    
    Abstract available

  56. YANG Z, Yi W, Tao J, Liu X, et al
    HPVMD-C: a disease-based mutation database of human papillomavirus in China.
    Database (Oxford). 2022;2022.
    PubMed    
    Abstract available

  57. LIU Z, Huang J, Jiang Q, Li X, et al
    miR-125a attenuates the malignant biological behaviors of cervical squamous cell carcinoma cells through Rad51.
    Bioengineered. 2022;13:8503-8514.
    PubMed    
    Abstract available

  58. HE C, Liu L
    Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.
    Bioengineered. 2022;13:8311-8322.
    PubMed    
    Abstract available

  59. KASEKA PU, Kayira A, Chimbatata CS, Chisale MRO, et al
    Histopathological profile of cervical biopsies in northern Malawi: a retrospective cross-sectional study.
    BMJ Open. 2022;12:e048283.
    PubMed    
    Abstract available

  60. CASTRO-AMAYA AM, Fernandez-Avila L, Barron-Gallardo CA, Moreno-Rios CE, et al
    E6/E7 from Beta-2-HPVs 122, 38b, and 107 possess transforming properties in a fibroblast model in vitro.
    Exp Cell Res. 2022;414:113088.
    PubMed    
    Abstract available

  61. MIYOSHI A, Ueda Y, Yagi A, Kimura T, et al
    Challenge to improve Japan's deplorable HPV vaccination rate by local government actions.
    J Obstet Gynaecol Res. 2022;48:1233-1239.
    PubMed    
    Abstract available

  62. CARTER J, Abu-Rustum NR, Saban S, Chen LY, et al
    Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes.
    JCO Clin Cancer Inform. 2022;6:e2100154.
    PubMed    
    Abstract available

  63. QUERLEU D, Hudry D, Narducci F, Rychlik A, et al
    Radical Hysterectomy After the LACC Trial: Back to Radical Vaginal Surgery.
    Curr Treat Options Oncol. 2022;23:227-239.
    PubMed    
    Abstract available

  64. MUROI K, Kakushima N, Furukawa K, Furune S, et al
    Effects of steroid use for stenosis prevention after endoscopic submucosal dissection for cervical esophageal cancer.
    Int J Clin Oncol. 2022;27:940-947.
    PubMed    
    Abstract available

  65. AMPONSAH-DACOSTA E, Blose N, Nkwinika VV, Chepkurui V, et al
    Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
    Front Public Health. 2022;10:799984.
    PubMed    
    Abstract available

  66. BROWNE S, Feemster KA
    Human papillomavirus: optimizing opportunities for prevention.
    Curr Opin Pediatr. 2022;34:132-139.
    PubMed    
    Abstract available

  67. INZANI F, Angelico G, Santoro A, Travaglino A, et al
    SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix.
    Virchows Arch. 2022;480:873-877.
    PubMed    
    Abstract available

  68. COLBERT LE, El MB, Lynn EJ, Bronk J, et al
    Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16(+) Cancers.
    Cancer Immunol Res. 2022;10:259-271.
    PubMed    
    Abstract available

  69. BEHR CM, Koffijberg H, Degeling K, Vliegenthart R, et al
    Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation.
    Eur Radiol. 2022;32:3067-3075.
    PubMed    
    Abstract available

  70. RIVERA-COLON G, Zheng W
    Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
    Semin Diagn Pathol. 2022;39:213-227.
    PubMed    
    Abstract available

  71. MUDHIGETI N, Kalawat U, Hulikal N, Racherla RG, et al
    E6-E7 based nested multiplex PCR assay for genital HPV detection and simultaneous typing of 15 high and low-risk HPV types.
    Indian J Med Microbiol. 2022;40:18-23.
    PubMed    
    Abstract available

  72. SITARZ K, Czamara K, Szostek S, Kaczor A, et al
    The impact of HPV infection on human glycogen and lipid metabolism - a review.
    Biochim Biophys Acta Rev Cancer. 2022;1877:188646.
    PubMed    
    Abstract available

  73. SHI H, Ye L, Lu W, Lu B, et al
    Grading of endocervical adenocarcinoma: a novel prognostic system based on tumor budding and cell cluster size.
    Mod Pathol. 2022;35:524-532.
    PubMed    
    Abstract available

  74. SUD S, Weiner AA, Wang AZ, Gupta GP, et al
    Prognostic and Predictive Clinical and Biological Factors in HPV Malignancies.
    Semin Radiat Oncol. 2021;31:309-323.
    PubMed    
    Abstract available

  75. DAHLSTROM KR, Day AT, Sturgis EM
    Prevention and Screening of HPV Malignancies.
    Semin Radiat Oncol. 2021;31:297-308.
    PubMed    
    Abstract available

  76. SCOTT-WITTENBORN N, Fakhry C
    Epidemiology of HPV Related Malignancies.
    Semin Radiat Oncol. 2021;31:286-296.
    PubMed    
    Abstract available

  77. OZTURK R, Bakir S, Kazankaya F, Paker S, et al
    Awareness about Gynecologic Cancers and Related Factors among Healthy Women: A Cross-Sectional Study.
    Soc Work Public Health. 2021;36.
    PubMed    
    Abstract available

  78. PAN D, Machado L, Bica CG, Machado AK, et al
    In Vitro Evaluation of Antioxidant and Anticancer Activity of Lemongrass (Cymbopogon citratus (D.C.) Stapf).
    Nutr Cancer. 2022;74:1474-1488.
    PubMed    
    Abstract available

  79. ADAM EE, White MC, Saraiya M
    Higher prevalence of hysterectomy among rural women than urban women: Implications for measures of disparities in uterine and cervical cancers.
    J Rural Health. 2022;38:416-419.
    PubMed    
    Abstract available

  80. STOLTZFUS KC, Popalis ML, Reiter PL, Moss JL, et al
    Perspectives on self-sampling for cancer screening among rural and urban women: Multilevel factors related to acceptability.
    J Rural Health. 2022;38:391-397.
    PubMed    
    Abstract available

  81. ADEGBOYEGA A, Dignan M, Sha S, Nkwonta C, et al
    Psychological factors among Appalachian women with abnormal Pap results.
    J Rural Health. 2022;38:382-390.
    PubMed    
    Abstract available

  82. LEE DH, Kim ET, Jo HB, Hwang SY, et al
    Spontaneous reduction of transvaginal small bowel evisceration after abdominal hysterectomy for cervical cancer: A case report.
    Medicine (Baltimore). 2022;101:e29225.
    PubMed    
    Abstract available

  83. CHEN H, Zhao L, Liu J, Zhou H, et al
    Bioinformatic Analyzes of the Association Between Upregulated Expression of JUN Gene via APOBEC-Induced FLG Gene Mutation and Prognosis of Cervical Cancer.
    Front Med (Lausanne). 2022;9:815450.
    PubMed    
    Abstract available

  84. GANGOPADHYAY A
    Elimination of cervical cancer as a public health problem-how shorter brachytherapy could make a difference during COVID-19.
    Ecancermedicalscience. 2022;16:1352.
    PubMed    
    Abstract available

  85. BANERJEE D, Mittal S, Mandal R, Basu P, et al
    Screening technologies for cervical cancer: Overview.
    Cytojournal. 2022;19:23.
    PubMed    
    Abstract available

  86. LIM TSC, Ismail-Pratt I, Goh LH
    Cervical cancer screening and vaccination: understanding the latest guidelines.
    Singapore Med J. 2022;63:125-129.
    PubMed    


  87. PENG T, Lin S, Meng Y, Gao P, et al
    LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT).
    Cell Cycle. 2022 May 4. doi: 10.1080/15384101.2022.2073047.
    PubMed    
    Abstract available

  88. YURTCU E, Dogan RA, Karaaslan B, Mutlu S, et al
    Relationship between awareness of cervical cancer and HPV infection and attitudes towards HPV vaccine among women aged 15-49 years: a cross-sectional study.
    Sao Paulo Med J. 2022 Apr 29. pii: S1516-31802022005007203.
    PubMed    
    Abstract available

  89. NASCIMENTO J, Mariot C, Vianna DRB, Kliemann LM, et al
    Fatty acid synthase as a potential new therapeutic target for cervical cancer.
    An Acad Bras Cienc. 2022;94:e20210670.
    PubMed    
    Abstract available

  90. NERY EC, Neto AMS, Lyra JS, Ferreira MES, et al
    Plasma antioxidant capacity in cervical cancer patients.
    An Acad Bras Cienc. 2022;94:e20201733.
    PubMed    
    Abstract available

  91. HUANG K, Xu L, Jia M, Liu W, et al
    Second primary malignancies in cervical cancer and endometrial cancer survivors: a population-based analysis.
    Aging (Albany NY). 2022;14.
    PubMed    
    Abstract available

  92. SURAN M
    Why US Cervical Cancer Survival Rates Haven't Improved for Decades.
    JAMA. 2022 May 4. pii: 2792162. doi: 10.1001/jama.2022.4681.
    PubMed    


  93. KEYVANI F, Debnath N, Ayman Saleh M, Poudineh M, et al
    An integrated microfluidic electrochemical assay for cervical cancer detection at point-of-care testing.
    Nanoscale. 2022 May 4. doi: 10.1039/d1nr08252.
    PubMed    
    Abstract available

  94. HWANG WY, Suh DH, Kim K, Kim YB, et al
    Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer.
    Cancer Control. 2022;29:10732748221097778.
    PubMed    
    Abstract available

  95. WEN Q, Wang X, Lv J, Guo Y, et al
    Association between involuntary smoking and risk of cervical cancer in Chinese female never smokers: A prospective cohort study.
    Environ Res. 2022 Apr 30:113371. doi: 10.1016/j.envres.2022.113371.
    PubMed    
    Abstract available

  96. LIU S, Zhang Q, Liu W, Huang X, et al
    Research on the mechanisms of Shu Yu wan in the treatment of cervical cancer based on network pharmacology analyses and molecular docking technology.
    Nat Prod Res. 2022 May 3:1-5. doi: 10.1080/14786419.2022.2071884.
    PubMed    
    Abstract available

  97. GUPTE R, Lin KY, Nandu T, Lea JS, et al
    Combinatorial Treatment with Poly(ADP-ribose) Polymerase-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth Through Fos-Driven Changes in Gene Expression.
    Mol Cancer Res. 2022 May 3. pii: 696277. doi: 10.1158/1541-7786.MCR-22-0111.
    PubMed    
    Abstract available

  98. SHEN L, Dang J, Liu S, Xian B, et al
    CircRNA VPRBP inhibits tumorigenicity of cervical cancer via miR-93-5p/FRMD6 axis.
    Reprod Sci. 2022 May 2. pii: 10.1007/s43032-022-00923.
    PubMed    
    Abstract available

  99. ZHANG Y, Li J, Yang F, Zhang X, et al
    Relationship and prognostic significance of IL-33, PD-1/PD-L1, and tertiary lymphoid structures in cervical cancer.
    J Leukoc Biol. 2022 May 2. doi: 10.1002/JLB.5MA0322.
    PubMed    
    Abstract available

  100. DZOBO M, Dzinamarira T, Kgarosi K, Mashamba-Thompson TP, et al
    Human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review protocol.
    BMJ Open. 2022;12:e056140.
    PubMed    
    Abstract available

  101. DELPERO E, Selk A
    Shifting from cytology to HPV testing for cervical cancer screening in Canada.
    CMAJ. 2022;194:E613-E615.
    PubMed    


  102. ADIGA D, Bhat S, Chakrabarty S, Kabekkodu SP, et al
    DOC2B is a Negative Regulator of Wnt/beta-catenin Signaling Pathway in Cervical Cancer.
    Pharmacol Res. 2022 Apr 29:106239. doi: 10.1016/j.phrs.2022.106239.
    PubMed    
    Abstract available

  103. SONG SY, Lee SY, Ko YB, Kim J, et al
    Fenofibrate Exerts Anticancer Effects on Human Cervical Cancer HeLa Cells via Caspase-Dependent Apoptosis and Cell Cycle Arrest.
    Gynecol Obstet Invest. 2022;87:79-88.
    PubMed    
    Abstract available

  104. SHANG C, Li Y, He T, Liao Y, et al
    The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
    J Adv Res. 2021;37:169-184.
    PubMed    
    Abstract available

  105. WANG Z, Sun BS, Chen ZS, Zhao KK, et al
    FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance.
    Anal Cell Pathol (Amst). 2022;2022:9675466.
    PubMed    
    Abstract available

  106. LI J, Kong WM
    PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.
    J Immunol Res. 2022;2022:4510462.
    PubMed    
    Abstract available

  107. YU L, Guo Y, Che T
    The Effect of Pilates Exercise Nursing Combined with Communication Standard-Reaching Theory Nursing and Pelvic Floor Muscle Training on Bladder Function and Family Function of Patients after Cervical Cancer Surgery.
    Comput Math Methods Med. 2022;2022:6444462.
    PubMed    
    Abstract available

  108. MOHAN L, Karthika M
    A community-based cervical cancer screening program in Alappuzha district of Kerala using camp approach.
    J Family Med Prim Care. 2022;11:1152-1157.
    PubMed    
    Abstract available

  109. CHEN K, Yan Z, Dong X, Liang Y, et al
    Genetic Polymorphisms in microRNA Genes Targeting PI3K/Akt Signal Pathway Modulate Cervical Cancer Susceptibility in a Chinese Population.
    Front Genet. 2022;13:856505.
    PubMed    
    Abstract available

  110. XU Z, Traughber BJ, Harris E, Podder TK, et al
    Effect of applicator removal from target volume for cervical cancer patients treated with Venezia high-dose-rate brachytherapy applicator.
    J Contemp Brachytherapy. 2022;14:176-182.
    PubMed    
    Abstract available

  111. MOGHANI MM, Siavashpour Z, Ogorodniitchouk O, Moreno-Acosta P, et al
    Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators.
    J Contemp Brachytherapy. 2022;14:183-188.
    PubMed    
    Abstract available

  112. CHEN X, Liang W, Duan H, Wu M, et al
    Discussion on the Treatment Strategy for Stage A1 Cervical Cancer (FIGO 2018).
    Front Oncol. 2022;12:800049.
    PubMed    
    Abstract available

  113. BEYER K, Kasasa S, Anguzu R, Lukande R, et al
    High-resolution disease maps for cancer control in low-resource settings: A spatial analysis of cervical cancer incidence in Kampala, Uganda.
    J Glob Health. 2022;12:04032.
    PubMed    
    Abstract available

  114. JIANG Y, Li T, Qian Y, Zuo X, et al
    Morphine in Combination with Ketamine Improves Cervical Cancer Pain and Suppresses Immune Function via the JAK3/STAT5 Pathway.
    Pain Res Manag. 2022;2022:9364365.
    PubMed    
    Abstract available

  115. CORTES-SARABIA K, Alarcon-Romero LDC, Flores-Alfaro E, Illades-Aguiar B, et al
    Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer.
    Biomed J. 2021;44.
    PubMed    
    Abstract available

  116. MAGKANA M, Mentzelopoulou P, Magkana E, Pampanos A, et al
    p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening.
    Anticancer Res. 2022;42:2599-2606.
    PubMed    
    Abstract available

  117. AWAN UA, Khattak AA
    Has Pakistan failed to roll back HPV?
    Lancet Oncol. 2022;23:e204.
    PubMed    


  118. RUAN X, Jiang J
    RACGAP1 promotes proliferation and cell cycle progression by regulating CDC25C in cervical cancer cells.
    Tissue Cell. 2022;76:101804.
    PubMed    
    Abstract available

  119. WU M, Chen G, Liao X, Xiao L, et al
    YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.
    Drug Dev Res. 2022 Apr 30. doi: 10.1002/ddr.21942.
    PubMed    
    Abstract available

  120. WEI XN, Xu XY, Wang SW
    [Infection and distribution characteristics of HPV of middle-aged and elderly women from a certain hospital in Guangxi Zhuang Autonomous Region from 2018 to 2020].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56:468-473.
    PubMed    
    Abstract available

  121. ZHU JJ, Wang JT, Gong L, Ran ZX, et al
    [A nested case-control study on the relationship between red blood cell folate and the prognosis of low-grade cervical intraepithelial neoplasia].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56:453-458.
    PubMed    
    Abstract available

  122. AYATOLLAHI H, Rajabi E, Yekta Z, Jalali Z, et al
    Efficacy of Oral Zinc Sulfate Supplementation on Clearance of Cervical Human Papillomavirus (HPV); A Randomized Controlled Clinical Trial.
    Asian Pac J Cancer Prev. 2022;23:1285-1290.
    PubMed    
    Abstract available

  123. SOLIKHAH S, Perwitasari DA, Rejeki DSS
    Geographic Characteristics of Various Cancers in Yogyakarta Province, Indonesia: A Spatial Analysis at the Community Level.
    Asian Pac J Cancer Prev. 2022;23:1231-1238.
    PubMed    
    Abstract available

  124. SCHROER-GUNTHER M, Koch K
    [The informed decision as an aim of evidence-based health information: the example of cancer screening].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022.
    PubMed    
    Abstract available

  125. GONG M, Chen C, Zhao H, Guo L, et al
    Analysis of Distributions of HPV Infection in Females with Cervical Lesions in the Western District of Beijing Chaoyang Hospital.
    J Healthc Eng. 2022;2022:5422748.
    PubMed    
    Abstract available

  126. GUPTA S, Panda PK, Hashimoto RF, Samal SK, et al
    Dynamical modeling of miR-34a, miR-449a, and miR-16 reveals numerous DDR signaling pathways regulating senescence, autophagy, and apoptosis in HeLa cells.
    Sci Rep. 2022;12:4911.
    PubMed    
    Abstract available

  127. TABERNERO J, Andre F, Blay JY, Bustillos A, et al
    Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.
    ESMO Open. 2022;7:100419.
    PubMed    
    Abstract available

  128. DUAN R, Xu K, Huang L, Yuan M, et al
    Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007-2030.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1130-1136.
    PubMed    
    Abstract available

  129. LOGEL M, Laurie C, El-Zein M, Guichon J, et al
    A Review of Ethical and Legal Aspects of Gender-Neutral Human Papillomavirus Vaccination.
    Cancer Epidemiol Biomarkers Prev. 2022;31:919-931.
    PubMed    
    Abstract available

  130. LIM AW
    Non-speculum sampling for cervical screening.
    Br J Gen Pract. 2022;72:106.
    PubMed    


  131. ACHARYA S
    A View on the PARCER Trial.
    J Clin Oncol. 2022;40:1130.
    PubMed    


  132. CHOPRA S, Kannan S, Gupta S
    Reply to S. Acharya.
    J Clin Oncol. 2022;40:1130-1131.
    PubMed    


  133. XU M, Huo C, Huang C, Wu B, et al
    Feasibility of the "Cuff-Sleeve" Suture Method for Functional Neocervix Reconstruction in Laparoscopic Radical Trachelectomy: A Retrospective Analysis.
    J Minim Invasive Gynecol. 2022;29:673-682.
    PubMed    
    Abstract available

  134. JOHNSON LG, Saidu R, Svanholm-Barrie C, Boa R, et al
    Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening.
    Cancer Epidemiol Biomarkers Prev. 2022;31:595-603.
    PubMed    
    Abstract available

  135. CHOW S, Karam A
    Role of sentinel lymph node biopsy for gynecologic cancers.
    Curr Opin Obstet Gynecol. 2022;34:15-19.
    PubMed    
    Abstract available

  136. AI SAHLGREN H, Elfgren K, Sparen P, Elfstrom MK, et al
    Colposcopic performance in a birth cohort previously eligible for "Human Papillomavirus" vaccination.
    Am J Obstet Gynecol. 2021 Dec 23. pii: S0002-9378(21)02682.
    PubMed    
    Abstract available

  137. KARIA PS, Tehranifar P, Visvanathan K, Wright JD, et al
    Cancer-Specific Mortality in Asian American Women Diagnosed with Gynecologic Cancer: A Nationwide Population-Based Analysis.
    Cancer Epidemiol Biomarkers Prev. 2022;31:578-587.
    PubMed    
    Abstract available

  138. DUGGAN MA, Duan Q, Pfeiffer RM, Brett MA, et al
    Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.
    Appl Immunohistochem Mol Morphol. 2022;30:91-98.
    PubMed    
    Abstract available

  139. CITAK BILGIN N, Coskuner Potur D, Yildirim G
    Does group education affect mothers' knowledge and attitudes towards the HPV vaccine?
    Health Care Women Int. 2022;43:686-704.
    PubMed    
    Abstract available

  140. FISHER H, Hickman M, Ferrie J, Evans K, et al
    Impact of new consent procedures on uptake of the schools-based human papillomavirus (HPV) vaccination programme.
    J Public Health (Oxf). 2022;44:199-206.
    PubMed    
    Abstract available

  141. ZHANG Y, Cheng L, Shi X, Song Y, et al
    The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.
    Int J Biol Sci. 2022;18:2994-3005.
    PubMed    
    Abstract available

  142. SARAH MARIA N, Olwit C, Kaggwa MM, Nabirye RC, et al
    Cervical cancer screening among HIV-positive women in urban Uganda: a cross sectional study.
    BMC Womens Health. 2022;22:148.
    PubMed    
    Abstract available

  143. BONFUL HA, Addo-Lartey AA, Sefenu RS, Nwameme A, et al
    Developing a culturally tailored short message service (SMS) intervention for improving the uptake of cervical cancer screening among Ghanaian women in urban communities.
    BMC Womens Health. 2022;22:154.
    PubMed    
    Abstract available

  144. ZHOU L, Qiu Q, Zhou Q, Li J, et al
    Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer.
    Nat Commun. 2022;13:2563.
    PubMed    
    Abstract available

  145. ZHANG Q, Zheng J, Liu L
    Down-regulation of lncRNA LUADT1 suppresses cervical cancer cell growth by sequestering microRNA-1207-5p.
    Acta Biochim Biophys Sin (Shanghai). 2022;54:321-331.
    PubMed    
    Abstract available


  146. One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer.
    Saudi Med J. 2022;43:538.
    PubMed    
    Abstract available

  147. XU M, Huo C, Huang C, Liu Y, et al
    Round ligament suspension and vaginal purse-string suture: Newly optimized techniques to prevent tumor spillage in laparoscopic radical trachelectomy for cervical cancer.
    J Obstet Gynaecol Res. 2022 May 10. doi: 10.1111/jog.15278.
    PubMed    
    Abstract available

  148. ZHUANG Y, Huang Y, He Z, Liu T, et al
    Effect of substrate stiffness on the mechanical properties of cervical cancer cells.
    Arch Biochem Biophys. 2022 May 7:109281. doi: 10.1016/j.abb.2022.109281.
    PubMed    
    Abstract available

  149. SONG X, Li R, Wang H, Song P, et al
    Tisotumab vedotin for the treatment of cervical carcinoma.
    Drugs Today (Barc). 2022;58:213-222.
    PubMed    
    Abstract available

  150. ENDALE H, Mulugeta T, Habte T
    The Socioeconomic Impact of Cervical Cancer on Patients in Ethiopia: Evidence from Tikur Anbessa Specialized Hospital.
    Cancer Manag Res. 2022;14:1615-1625.
    PubMed    
    Abstract available

  151. LIN Y, Wang X
    Analysis of the Role and Mechanism of ZEB1 in Regulating Cervical Carcinoma Progression via Modulating PD-1/PD-L1 Checkpoint.
    Comput Math Methods Med. 2022;2022:1565094.
    PubMed    
    Abstract available

  152. LIU J, Su S, Liu Y
    The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL.
    Sci Rep. 2022;12:7613.
    PubMed    
    Abstract available

  153. LIU Y, Li H, Zheng Z, Niu A, et al
    Rosa rugosa polysaccharide induces autophagy-mediated apoptosis in human cervical cancer cells via the PI3K/AKT/mTOR pathway.
    Int J Biol Macromol. 2022 May 6. pii: S0141-8130(22)00978.
    PubMed    
    Abstract available

  154. PERRUCCI E, Cerrotta A, Macchia G, Augurio A, et al
    Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups.
    Crit Rev Oncol Hematol. 2022 May 6:103704. doi: 10.1016/j.critrevonc.2022.103704
    PubMed    
    Abstract available

  155. MUTLU L, Tymon-Rosario J, Harold J, Menderes G, et al
    Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer.
    Expert Rev Anticancer Ther. 2022 May 9. doi: 10.1080/14737140.2022.2075348.
    PubMed    
    Abstract available

  156. ZHANG X, Zheng X
    Hsa_circ_0001495 contributes to cervical cancer progression by targeting miR-526b-3p/TMBIM6/mTOR axis.
    Reprod Biol. 2022;22:100648.
    PubMed    
    Abstract available

  157. CARCOPINO X, Cruickshank M, Leeson S, Redman C, et al
    The Impact of COVID-19 Pandemic on Screening Programs for Cervical Cancer Prevention Across Europe.
    J Low Genit Tract Dis. 2022 May 6. pii: 00128360-990000000-00005.
    PubMed    
    Abstract available

  158. XIAO C, Jin J, Yi J, Han C, et al
    RefineNet-based 2D and 3D automatic segmentations for clinical target volume and organs at risks for patients with cervical cancer in postoperative radiotherapy.
    J Appl Clin Med Phys. 2022 May 9:e13631. doi: 10.1002/acm2.13631.
    PubMed    
    Abstract available

  159. LANTSMAN T, Lepe M, Garrett L, Goodman M, et al
    Management of recurrent cervical cancer with peritoneal carcinomatosis with HIPEC.
    Gynecol Oncol Rep. 2021;39:100909.
    PubMed    
    Abstract available

  160. YUAN J, Lai Y, Li T
    Ovarian protection and safety of gonadotropin-releasing hormone agonist after cervical cancer surgery: systematic review and meta-analysis.
    Ann Transl Med. 2022;10:409.
    PubMed    
    Abstract available

  161. GLANE LT, Hegele A, Wagner U, Boekhoff J, et al
    Gynecologic Oncology: Pelvic Exenteration for Advanced or Recurring Cervical Cancer - A Single Center Analysis.
    Cancer Diagn Progn. 2022;2:308-315.
    PubMed    
    Abstract available

  162. XUE Z, Angara S, Levitz D, Antani S, et al
    Analysis of digital noise and reduction methods on classifiers used in automated visual evaluation in cervical cancer screening.
    Proc SPIE Int Soc Opt Eng. 2022;11950.
    PubMed    
    Abstract available

  163. NISA N, Wahyuningsih SPA, Darmanto W, Purnama PR, et al
    Effect of the Ethanol Extract of Red Okra Pods (Abelmoschus esculentus (L.) Moench) to Inhibit Cervical Cancer Cells Growth through Cell Cycle-Associated Oncogenes.
    Scientifica (Cairo). 2022;2022:1094771.
    PubMed    
    Abstract available

  164. ZHANG J, Ju X, Feng Z, Zhang X, et al
    Progressive resistance exercise training to prevent lower-limb lymphedema after cervical cancer surgery: A feasibility study.
    Asia Pac J Oncol Nurs. 2021;9:32-38.
    PubMed    
    Abstract available

  165. LIU Y, Zhao R, Qin X, Mao X, et al
    Cobimetinib Sensitizes Cervical Cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation.
    Pharmacology. 2022 May 6:1-8. doi: 10.1159/000524305.
    PubMed    
    Abstract available

  166. HORIBA Y, Yoshino T, Yokota M, Iwata T, et al
    Climacteric symptoms in postoperative patients among endometrial cancer, cervical cancer, and ovarian cancer: a cross-sectional study.
    Support Care Cancer. 2022 May 8. pii: 10.1007/s00520-022-07117.
    PubMed    
    Abstract available

  167. YANG T, Tian S, Wang Y, Ji J, et al
    Antitumor activity of pachymic acid in cervical cancer through inducing endoplasmic reticulum stress, mitochondrial dysfunction, and activating the AMPK pathway.
    Environ Toxicol. 2022 May 7. doi: 10.1002/tox.23555.
    PubMed    
    Abstract available

  168. BRAVINGTON A, Chen H, Dyson J, Jones L, et al
    Translating qualitative data into intervention content using the Theoretical Domains Framework and stakeholder co-design: a worked example from a study of cervical screening attendance in older women.
    BMC Health Serv Res. 2022;22:610.
    PubMed    
    Abstract available

  169. CHANG X, Yuan Y, Wang G, Hu L, et al
    The effects of intestinal air cavity on dose distribution of volume modulated arc therapy for cervical cancer.
    Ann Palliat Med. 2022;11:1326-1335.
    PubMed    
    Abstract available

  170. PIRET EM, Payne BA, Smith LW, Trawin J, et al
    Side effects and acceptability measures for thermal ablation as a treatment for cervical precancer in low-income and middle-income countries: a systematic review and meta-synthesis.
    Fam Med Community Health. 2022;10.
    PubMed    
    Abstract available

  171. LI N, Geng F, Liang SM, Qin X, et al
    USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-kappaB/PD-L1 axis to promote the development of cervical cancer.
    Cell Signal. 2022 May 3:110351. doi: 10.1016/j.cellsig.2022.110351.
    PubMed    
    Abstract available

  172. TENG Y, Ai Y, Liang T, Yu B, et al
    The Effects of Automatic Segmentations on Preoperative Lymph Node Status Prediction Models With Ultrasound Radiomics for Patients With Early Stage Cervical Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221099396.
    PubMed    
    Abstract available

  173. MOLOKWU JC, Dwivedi A, Alomari A, Guzman J, et al
    Effect of Text Message Reminders on Attendance at Cervical Cancer Screening Appointments in a Predominantly Hispanic Population.
    Hisp Health Care Int. 2022 May 6:15404153221098950.
    PubMed    
    Abstract available

  174. TONG Y, Orang'o E, Nakalembe M, Tonui P, et al
    The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS.
    Ann Med. 2022;54:1202-1211.
    PubMed    
    Abstract available

  175. ZHENG X, Wu G, Wang J, Yin L, et al
    Rapid detection of hysteromyoma and cervical cancer based on serum surface-enhanced Raman spectroscopy and a support vector machine.
    Biomed Opt Express. 2022;13:1912-1923.
    PubMed    
    Abstract available

  176. LIU B, Zhai J, Wang W, Liu T, et al
    Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.
    Front Mol Biosci. 2022;9:872932.
    PubMed    
    Abstract available

  177. ZHAO MY, Liu P, Sun C, Pei LJ, et al
    Propofol Augments Paclitaxel-Induced Cervical Cancer Cell Ferroptosis In Vitro.
    Front Pharmacol. 2022;13:816432.
    PubMed    
    Abstract available

  178. SUN YH, Chou YH, Tsai HY, Hsiao YH, et al
    Impact of Genetic Variants of Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 on Uterine Cervical Cancer.
    J Cancer. 2022;13:2150-2158.
    PubMed    
    Abstract available

  179. WANG J, Zhang KS, Liu Z, Wang T, et al
    Using New Vaginal Doses Evaluation System to Assess the Dose-Effect Relationship for Vaginal Stenosis After Definitive Radio(Chemo)Therapy for Cervical Cancer.
    Front Oncol. 2022;12:840144.
    PubMed    
    Abstract available

  180. MENON G, Baldwin L, Heikal A, Burke B, et al
    Brachytherapy workflow for locally advanced cervical cancer: A survey of Canadian Medical Physicists.
    Brachytherapy. 2022 May 2. pii: S1538-4721(22)00039.
    PubMed    
    Abstract available

  181. YANG M, Hu H, Wu S, Ding J, et al
    EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression.
    J Exp Clin Cancer Res. 2022;41:165.
    PubMed    
    Abstract available

  182. SILVESTRIS E, Paradiso AV, Minoia C, Daniele A, et al
    Fertility preservation techniques in cervical carcinoma.
    Medicine (Baltimore). 2022;101:e29163.
    PubMed    
    Abstract available

  183. ALAM Z, Ann Dean J, Janda M
    Cervical screening uptake: A cross-sectional study of self-reported screening attitudes, behaviours and barriers to participation among South Asian immigrant women living in Australia.
    Womens Health (Lond). 2022;18:17455057221096240.
    PubMed    
    Abstract available

  184. JAMES LM, Georgopoulos AP
    Immunogenetic clustering of 30 cancers.
    Sci Rep. 2022;12:7235.
    PubMed    
    Abstract available

  185. NEMEC M, Waller J, Barnes J, Marlow LAV, et al
    Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England.
    BMJ Open. 2022;12:e058635.
    PubMed    
    Abstract available

  186. HOPE H, Pierce M, Johnstone ED, Myers J, et al
    The sexual and reproductive health of women with mental illness: a primary care registry study.
    Arch Womens Ment Health. 2022;25:585-593.
    PubMed    
    Abstract available

  187. WANG B, Zhang H, Wei L, Li Y, et al
    Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry.
    J Healthc Eng. 2022;2022:9288476.
    PubMed    
    Abstract available

  188. BAMIDELE OO, Green T, Tookey S, Walabyeki J, et al
    A qualitative exploration of women's perspectives and acceptability of including new cancer awareness information in all-clear breast or cervical screening results.
    Eur J Cancer Care (Engl). 2022;31:e13574.
    PubMed    
    Abstract available

  189. WANG D, Wu J, Du J, Ong H, et al
    Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature.
    Eur J Cancer Care (Engl). 2022;31:e13566.
    PubMed    
    Abstract available

  190. ZHU D, Hao Q, Qian M, Hu Y, et al
    LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future.
    J Healthc Eng. 2022;2022:8387458.
    PubMed    
    Abstract available

  191. HENDRIKS N, Koeneman MM, van de Sande AJM, Penders CGJ, et al
    Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study.
    J Immunother. 2022;45:180-186.
    PubMed    
    Abstract available

  192. TUNG WC, Jones D, Lu M
    Sources of Information and Communication About HPV Among Chinese Students Attending U.S. Colleges: Implications for Culturally Appropriate Strategies.
    J Transcult Nurs. 2022;33:437-445.
    PubMed    
    Abstract available

  193. SOMEYA M, Fukushima Y, Hasegawa T, Tsuchiya T, et al
    Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy.
    Jpn J Radiol. 2022;40:458-465.
    PubMed    
    Abstract available

  194. FITZPATRICK P, Mooney T, Byrne H, Healy O, et al
    Interval cancer audit and disclosure in cervical screening programmes: An international survey.
    J Med Screen. 2022;29:104-109.
    PubMed    
    Abstract available

  195. ZENG Z, Austin RM, Wang L, Guo X, et al
    Nationwide Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection in China.
    Am J Clin Pathol. 2022;157:718-723.
    PubMed    
    Abstract available

  196. SEAY J, Matsuno R, Buechel J, Tannenbaum K, et al
    HPV-Related Cancers: A Growing Threat to U.S. Military Health and Readiness.
    Mil Med. 2022;187.
    PubMed    
    Abstract available

  197. BHATTACHARYA M, Xiong S, McRee AL
    Nativity Differences in Awareness and Knowledge About HPV Infection and Vaccination Among U.S. Adults: Findings from a National Population-Based Sample.
    J Immigr Minor Health. 2022;24:794-798.
    PubMed    
    Abstract available

  198. ZHUANG J, Guan M
    Modeling the Mediating and Moderating Roles of Risk Perceptions, Efficacy, Desired Uncertainty, and Worry in Information Seeking-Cancer Screening Relationship Using HINTS 2017 Data.
    Health Commun. 2022;37:897-908.
    PubMed    
    Abstract available

  199. HARPER DM
    Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status.
    J Clin Oncol. 2022 May 20:JCO2200609. doi: 10.1200/JCO.22.00609.
    PubMed    


  200. DE SK
    Tisotumab vedotin; First FDA Approved Antibody-drug Conjugate for Cervical Cancer.
    Anticancer Agents Med Chem. 2022 Apr 21. pii: ACAMC-EPUB-122733.
    PubMed    


  201. TEMBHURNE AK, Maheshwari A, Warke H, Chaudhari H, et al
    Killer cell immunoglobulin-like receptor (KIR) gene contents: Are they associated with cervical cancer?
    J Med Virol. 2022 May 20. doi: 10.1002/jmv.27873.
    PubMed    
    Abstract available

  202. ZHAN J, Yang F, Ge C, Yu X, et al
    Multi-Omics Approaches Identify NecroptosisRelated Prognostic Signature and Associated Regulatory Axis in Cervical Cancer.
    Int J Gen Med. 2022;15:4937-4948.
    PubMed    
    Abstract available

  203. WANG Q, Yan SP, Chu DX, Xie Y, et al
    Retraction Notice to: Silencing of Long Non-coding RNA RP1-93H18.6 Acts as a Tumor Suppressor in Cervical Cancer through the Blockade of the PI3K/Akt Axis.
    Mol Ther Nucleic Acids. 2022;28:537.
    PubMed    
    Abstract available

  204. KIM YJ, Ju W, Nam KH, Kim SN, et al
    RGB Channel Superposition Algorithm with Acetowhite Mask Images in a Cervical Cancer Classification Deep Learning Model.
    Sensors (Basel). 2022;22.
    PubMed    
    Abstract available

  205. CHEN H, Xia CF, You TT, Qiao YL, et al
    [Causes and countermeasures of the rapidly rising burden on cervical cancer in Chinese women].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43:761-765.
    PubMed    
    Abstract available

  206. YU X, Li Z, Bai R, Tang F, et al
    Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/beta-catenin signaling in cervical cancer.
    Bioengineered. 2022;13:12516-12531.
    PubMed    
    Abstract available

  207. SUN Y, Ling J, Liu L
    Collagen type X alpha 1 promotes proliferation, invasion and epithelial-mesenchymal transition of cervical cancer through activation of TGF-beta/Smad signaling.
    Physiol Int. 2022 May 18. doi: 10.1556/2060.2022.00006.
    PubMed    
    Abstract available

  208. WYATT LC, Chebli P, Patel S, Alam G, et al
    A Culturally Adapted Breast and Cervical Cancer Screening Intervention Among Muslim Women in New York City: Results from the MARHABA Trial.
    J Cancer Educ. 2022 May 19. pii: 10.1007/s13187-022-02177.
    PubMed    
    Abstract available

  209. GROSS GE
    [Immunoprevention of HPV-Associated Neoplasias].
    MMW Fortschr Med. 2022;164:56-60.
    PubMed    


  210. LI F, Zhu W, Wang Z
    Retraction Note: Long noncoding RNA LINC00460 promotes the progression of cervical cancer via regulation of the miR-361-3p/Gli1 axis.
    Hum Cell. 2022 May 18. pii: 10.1007/s13577-022-00723.
    PubMed    


  211. KING EM, Busolo DS
    The role of primary care Nurse Practitioners in reducing barriers to cervical cancer screening: A literature review.
    Can Oncol Nurs J. 2022;32:233-244.
    PubMed    
    Abstract available

  212. AVIAN A, Clemente N, Mauro E, Isidoro E, et al
    Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples.
    J Transl Med. 2022;20:231.
    PubMed    
    Abstract available

  213. YANG X, Chen Y, Li M, Zhu W, et al
    ERBB3 methylation and immune infiltration in tumor microenvironment of cervical cancer.
    Sci Rep. 2022;12:8112.
    PubMed    
    Abstract available

  214. BELLETI R, Marcolino LD, Novak J, Ferreira CST, et al
    Cervicovaginal loads of Gardnerella spp. are increased in immunocompetent women with persistent high-risk human papillomavirus infection.
    J Med Microbiol. 2022;71.
    PubMed    
    Abstract available

  215. GARCIA-BECERRA N, Aguilar-Lemarroy A, Jave-Suarez LF
    On the Regulation of NF-kappaB pathway by HPV Oncoproteins: Are pathway Inhibitors a good Alternative for the Treatment of Cervical Cancer?
    Anticancer Agents Med Chem. 2022 May 9. pii: ACAMC-EPUB-123256.
    PubMed    
    Abstract available

  216. RAN Z, Wu S, Ma Z, Chen X, et al
    Advances in exosome biomarkers for cervical cancer.
    Cancer Med. 2022 May 16. doi: 10.1002/cam4.4828.
    PubMed    
    Abstract available

  217. BONOW MP, Collaco LM, Percicote AP, Zanine RM, et al
    When is There no Benefit in Performing a Biopsy in the Suspicion of Intraepithelial Lesions of the Cervix?
    Rev Bras Ginecol Obstet. 2022;44:272-279.
    PubMed    
    Abstract available

  218. WEI WW, Wang H, Zheng H, Chen J, et al
    Survival Impacts of Perineural Invasion on Patients Under Different Radical Hysterectomies Due to Early Cervical Cancer.
    Front Oncol. 2022;12:889862.
    PubMed    
    Abstract available

  219. YI J, Liu Z, Wang L, Zhang X, et al
    Corrigendum: Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis.
    Front Oncol. 2022;12:916310.
    PubMed    
    Abstract available

  220. HU H, Yang M, Dong W, Yin B, et al
    A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer.
    Front Oncol. 2022;12:873725.
    PubMed    
    Abstract available

  221. EALA MAB, Tantengco OAG
    Global online interest in cervical cancer care in the time of COVID-19: An infodemiology study.
    Gynecol Oncol Rep. 2022;41:100998.
    PubMed    
    Abstract available

  222. ALSALMI SF, Othman SS
    Cervical Cancer Screening Uptake and Predictors Among Women in Jeddah, Saudi Arabia.
    Cureus. 2022;14:e24065.
    PubMed    
    Abstract available

  223. LILHORE UK, Poongodi M, Kaur A, Simaiya S, et al
    Hybrid Model for Detection of Cervical Cancer Using Causal Analysis and Machine Learning Techniques.
    Comput Math Methods Med. 2022;2022:4688327.
    PubMed    
    Abstract available

  224. ZHANG W, Xiao P, Tang J, Wang R, et al
    m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment.
    Front Immunol. 2022;13:888650.
    PubMed    
    Abstract available

  225. WANG Z, Ren X, Liu Z, Li Y, et al
    Multimodality treatment for multiple recurrences of cervical cancer after radiotherapy: a case report.
    Transl Cancer Res. 2022;11:943-951.
    PubMed    
    Abstract available

  226. HIMINIUC LM, Toma BF, Popovici R, Grigore AM, et al
    Update on the Use of Nanocarriers and Drug Delivery Systems and Future Directions in Cervical Cancer.
    J Immunol Res. 2022;2022:1636908.
    PubMed    
    Abstract available

  227. WANG Y, Zhang L, Liu W, Yang JP, et al
    Apatinib enhances the antitumor effects of radiation in HeLa cell line mouse model of invasive cervical cancer.
    Ann Transl Med. 2022;10:459.
    PubMed    
    Abstract available

  228. MEI L, Meng J, Wei D, Hu Q, et al
    Diagnostic test of bioimpedance-based neural network algorithm in early cervical cancer.
    Ann Transl Med. 2022;10:471.
    PubMed    
    Abstract available

  229. BIRGE O, Bakir MS, Dogan S, Tuncer HA, et al
    The Relationship Between Parametrial Involvement and Parametrial Tissue Removed in Radical Surgery in Early-Stage Cervical Cancer.
    World J Oncol. 2022;13:59-68.
    PubMed    
    Abstract available

  230. MUSA J, Kim K, Zheng Y, Qu Y, et al
    Accelerated Epigenetic Age Among Women with Invasive Cervical Cancer and HIV-Infection in Nigeria.
    Front Public Health. 2022;10:834800.
    PubMed    
    Abstract available

  231. LIU P, Jiang Y, Zheng X, Pan B, et al
    Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB.
    Pathol Oncol Res. 2022;28:1610294.
    PubMed    
    Abstract available

  232. HEGDE YM, Theivendren P, S G, P M, et al
    A Recent Advancement In Nanotechnology Approaches For The Treatment Of Cervical Cancer.
    Anticancer Agents Med Chem. 2022 May 13. pii: ACAMC-EPUB-123550.
    PubMed    
    Abstract available

  233. LYU X, Ding X, Ye H, Guo R, et al
    KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway.
    Discov Oncol. 2022;13:30.
    PubMed    
    Abstract available

  234. ECKER S, Zimmermann L, Heilemann G, Niatsetski Y, et al
    Neural network-assisted automated image registration for MRI-guided adaptive brachytherapy in cervical cancer.
    Z Med Phys. 2022 May 12. pii: S0939-3889(22)00057.
    PubMed    
    Abstract available

  235. MANZOUR N, Chiva L, Chacon E, Martin-Calvo N, et al
    ASO Visual Abstract: SUCCOR Risk-Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.
    Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11734.
    PubMed    


  236. CHRISTIE-DE JONG F, Kotzur M, Amiri R, Ling J, et al
    Qualitative evaluation of a codesigned faith-based intervention for Muslim women in Scotland to encourage uptake of breast, colorectal and cervical cancer screening.
    BMJ Open. 2022;12:e058739.
    PubMed    
    Abstract available

  237. COOPER SA, Henderson A, Kinnear D, Mackay D, et al
    Cohort profile: Scotland's record-linkage e-cohorts of people with intellectual disabilities, and autistic people (SCIDA).
    BMJ Open. 2022;12:e057230.
    PubMed    
    Abstract available

  238. ZHANG Y, Zhang K, Jia H, Xia B, et al
    IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
    Magn Reson Imaging. 2022;91:37-44.
    PubMed    
    Abstract available

  239. GILLOT L, Lebeau A, Baudin L, Pottier C, et al
    Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization.
    Cell Mol Life Sci. 2022;79:295.
    PubMed    
    Abstract available

  240. KIM JM, Chong GO, Park NJ, Choi YE, et al
    Survival Impact of Residual Cancer Cells in Intraoperative Peritoneal Washes following Radical Hysterectomy for Cervical Cancer.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  241. GRIGORE M, Vasilache IA, Cianga P, Constantinescu D, et al
    Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  242. VAN LUIJK IF, Smith SM, Marte Ojeda MC, Oei AL, et al
    A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  243. STANCA M, Capilna DM, Capilna ME
    Long-Term Survival, Prognostic Factors, and Quality of Life of Patients Undergoing Pelvic Exenteration for Cervical Cancer.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  244. CHANG CS, Shim JI, Byeon SJ, Lee EJ, et al
    Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  245. CHEN IN, Wang IT, Mu HY, Qiu JT, et al
    Comparison of Survival Outcomes between Minimally Invasive Surgery and Open Radical Hysterectomy in Early-Stage Cervical Cancer.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  246. GIL-IBANEZ B, Gil-Moreno A, Torne A, Martin Jimenez A, et al
    Tumor Size and Oncological Outcomes in Patients with Early Cervical Cancer Treated by Fertility Preservation Surgery: A Multicenter Retrospective Cohort Study.
    Cancers (Basel). 2022;14.
    PubMed    
    Abstract available

  247. WARNER ZC, Reid B, Auguste P, Joseph W, et al
    Awareness and Knowledge of HPV, HPV Vaccination, and Cervical Cancer among an Indigenous Caribbean Community.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  248. MEIRA KC, Magnago C, Mendonca AB, Duarte SFS, et al
    Inequalities in Temporal Effects on Cervical Cancer Mortality in States in Different Geographic Regions of Brazil: An Ecological Study.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  249. TAKAHASHI Y, Nishida H, Ichinose T, Miyagawa Y, et al
    Effect of Different Educational Interventions on Knowledge of HPV Vaccination and Cervical Cancer among Young Women: A Preliminary Report.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  250. DI FIORE R, Suleiman S, Drago-Ferrante R, Subbannayya Y, et al
    Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  251. HAN KH, Kim AK, Kim DI
    Enhanced Anti-Cancer Effects of Conditioned Medium from Hypoxic Human Adult Dermal Fibroblasts on Cervical Cancer Cells.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  252. LASCHE M, Gallwas J, Grundker C
    Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  253. HUSEINOVIC A, Jaspers A, van Splunter AP, Sorgard H, et al
    Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  254. ZHONG X, Zhang L, Dong T, Mai H, et al
    Clinical and MRI features of sacral insufficiency fractures after radiotherapy in patients with cervical cancer.
    BMC Womens Health. 2022;22:166.
    PubMed    
    Abstract available

  255. XIE S, Ding B, Wang S, Zhang X, et al
    Construction of hypoxia-immune-related prognostic model and targeted therapeutic strategies for cervical cancer.
    Int Immunol. 2022 May 13. pii: 6585640. doi: 10.1093.
    PubMed    
    Abstract available

  256. CHOUDHURY HK, Borah RK
    Can financial incentives encourage women to participate in a cervical cancer screening programme? Evidence from a randomized controlled trial analysis.
    J Cancer Policy. 2022;32:100324.
    PubMed    
    Abstract available

  257. AKANDA R, Kawale P, Moucheraud C
    Cervical cancer prevention in Africa: A policy analysis.
    J Cancer Policy. 2022;32:100321.
    PubMed    
    Abstract available

  258. LOMBE D, Msadabwe S, Maka M, Samboko M, et al
    Zambia cervical cancer control program resource mapping - Leveraging support to achieve the 90-70-90 elimination target.
    J Cancer Policy. 2021;28:100281.
    PubMed    
    Abstract available

  259. BAKER P, Kelly D, Medeiros R, Morrissey M, et al
    Eliminating HPV-caused cancers in Europe: Achieving the possible.
    J Cancer Policy. 2021;28:100280.
    PubMed    
    Abstract available

  260. DIRIRSA DE, Asefa EY, Awol Salo M
    Utilization of cervical cancer screening service and associated factors among women of reproductive age group in Ilu Abba Bor zone, southwestern Ethiopia, 2019: Cross-sectional study.
    SAGE Open Med. 2022;10:20503121221094904.
    PubMed    
    Abstract available

  261. CHENG YK, Kuo SH, Yen HH, Wu JH, et al
    The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumet
    Radiat Oncol. 2022;17:91.
    PubMed    
    Abstract available

  262. SADOUGHI F, Asemi Z, Yousefi B, Mansournia MA, et al
    Cervical cancer and novel therapeutic and diagnostic approaches using chitosan as a carrier: A review.
    Curr Pharm Des. 2022 May 12. pii: CPD-EPUB-123417.
    PubMed    
    Abstract available

  263. GIANNINI A, D'Oria O, Chiantera V, Margioula-Siarkou C, et al
    Minimally Invasive Surgery for Cervical Cancer: Should We Look beyond Squamous Cell Carcinoma?
    J Invest Surg. 2022 May 12:1-2. doi: 10.1080/08941939.2022.2075495.
    PubMed    


  264. MAHAPATRA E, Sengupta D, Kumar R, Dehury B, et al
    Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer.
    Front Pharmacol. 2022;13:803114.
    PubMed    
    Abstract available

  265. CAI C, Peng X, Zhang Y
    Serum IL-6 Level Predicts the Prognosis and Diagnosis in Cervical Cancer Patients.
    Int J Womens Health. 2022;14:655-663.
    PubMed    
    Abstract available

  266. MARUYAMA Y, Sukegawa A, Yoshida H, Iwaizumi Y, et al
    Role of cervical cancer screening during prenatal checkups for infectious diseases: A retrospective, descriptive study.
    J Int Med Res. 2022;50:3000605221097488.
    PubMed    
    Abstract available

  267. ZHAO R, Liang S, Teoh D, Fei Y, et al
    Correction: A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China.
    Infect Agent Cancer. 2022;17:21.
    PubMed    


  268. ZHAO J, Xue HD, Lin CY, Liu JJ, et al
    [Cervical Primary Ewing's Sarcoma:Report of One Case].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022;44:348-351.
    PubMed    
    Abstract available

  269. DONKOH ET, Asmah RH, Agyemang-Yeboah F, Dabo EO, et al
    Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
    Cancer Control. 2022;29:10732748221094721.
    PubMed    
    Abstract available

  270. VELICER C, Luxembourg A, Chen YT, Kohn M, et al
    Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection.
    Vaccine. 2022 May 5. pii: S0264-410X(22)00542.
    PubMed    


  271. WEN T, Xia C, Yu Q, Yu Y, et al
    A dual-signal electrochemical immunosensor for the detection of HPV16 E6 oncoprotein based on PdBP dendritic ternary nanospheres and MBSi-Chi nanocomposites.
    Analyst. 2022;147:2272-2279.
    PubMed    
    Abstract available

  272. MALEK M, Rahmani M, Pourashraf M, Amanpour-Gharaei B, et al
    Prediction of lymphovascular space invasion in cervical carcinoma using diffusion kurtosis imaging.
    Cancer Treat Res Commun. 2022;31:100559.
    PubMed    
    Abstract available

  273. ZHAO Y, Fu C, Xu S, Cao L, et al
    LFANet: Lightweight feature attention network for abnormal cell segmentation in cervical cytology images.
    Comput Biol Med. 2022;145:105500.
    PubMed    
    Abstract available

  274. HALL IJ, Rim SH, Dasari S
    Preventive care use among Hispanic adults with limited comfort speaking English: An analysis of the Medical Expenditure Panel Survey data.
    Prev Med. 2022;159:107042.
    PubMed    
    Abstract available

  275. PAN S, Wei W, Du X, Li Z, et al
    Factors associated with persistence and clearance of HPV16/18 among rural Chinese women: a cohort study in Wufeng, Hubei province.
    Women Health. 2022;62:276-286.
    PubMed    
    Abstract available

  276. SABIHI S, Vahedpoor Z, Saraf-Bank S, Nourian M, et al
    Effects of folate supplementation on recurrence and metabolic status of cervical intraepithelial neoplasia grade 2/3 in overweight and obese women: a randomized double-blind placebo-controlled trial.
    Eur J Clin Nutr. 2022;76:666-670.
    PubMed    
    Abstract available

  277. IDRES YM, McMillan NAJ, Idris A
    Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention.
    Mol Diagn Ther. 2022;26:301-308.
    PubMed    
    Abstract available

  278. VAZIFEHDOOST M, Eskandari F, Sohrabi A
    Trends in cocirculation of oncogenic HPV genotypes in single and multiple infections among the unvaccinated community.
    J Med Virol. 2022;94:3376-3385.
    PubMed    
    Abstract available

  279. PABORIBOUNE P, Phongsavan K, Arounlangsy P, Flaissier B, et al
    Efficacy of careHPV human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV-1 in Lao People's Democratic Republic.
    Cancer Med. 2022;11:1984-1994.
    PubMed    
    Abstract available

  280. DAS J, Maiti TK
    Fluid shear stress influences invasiveness of HeLa cells through the induction of autophagy.
    Clin Exp Metastasis. 2022;39:495-504.
    PubMed    
    Abstract available

  281. THORNTON C, Somayaji R, Chu A, Parkins MD, et al
    Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients.
    Thorax. 2022;77:625-627.
    PubMed    
    Abstract available

  282. ZHONG G, Wang Y, Yao S, Fang X, et al
    Squamous cell carcinoma antigen combined with HPV-16 infection in predicting high-grade squamous intraepithelial lesions of the cervix.
    J Obstet Gynaecol. 2022;42:696-700.
    PubMed    
    Abstract available

  283. GAO C, Wu P, Yu L, Liu L, et al
    The application of CRISPR/Cas9 system in cervical carcinogenesis.
    Cancer Gene Ther. 2022;29:466-474.
    PubMed    
    Abstract available

  284. MARLOW LAV, McBride E, Ridout D, Forster AS, et al
    Patterns of anxiety and distress over 12 months following participation in HPV primary screening.
    Sex Transm Infect. 2021 Aug 3. pii: sextrans-2020-054780.
    PubMed    
    Abstract available

  285. LUCIA F, Miranda O, Bourbonne V, Martin E, et al
    Integration of functional imaging in brachytherapy.
    Cancer Radiother. 2022;26:517-525.
    PubMed    
    Abstract available

  286. BOATMAN DD, Eason S, Conn ME, Kennedy-Rea SK, et al
    Human Papillomavirus Vaccine Messaging on TikTok: Social Media Content Analysis.
    Health Promot Pract. 2022;23:382-387.
    PubMed    
    Abstract available

  287. SYPIEN P, Zielonka TM
    Human papillomavirus vaccination - limatations and opportunities in countries with low vaccine coverage.
    Przegl Epidemiol. 2021;75:537-545.
    PubMed    
    Abstract available

  288. KAVYA KV, Vargheese S, Shukla S, Khan I, et al
    A cationic amino acid polymer nanocarrier synthesized in supercritical CO2 for co-delivery of drug and gene to cervical cancer cells.
    Colloids Surf B Biointerfaces. 2022;216:112584.
    PubMed    
    Abstract available

  289. JI M, Liu Y, Hu Y, Sun J, et al
    Comparison of recurrence patterns in cervical cancer patients with positive lymph nodes versus negative.
    Cancer Med. 2022 May 26. doi: 10.1002/cam4.4860.
    PubMed    
    Abstract available

  290. XU L, Li J, Tursun M, Hai Y, et al
    Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysisdependent AKT/mTOR signaling.
    Int J Oncol. 2022;61.
    PubMed    
    Abstract available

  291. REYNA-HERNANDEZ MA, Alarcon-Romero LDC, Ortiz-Ortiz J, Illades-Aguiar B, et al
    GLUT1, LDHA, and MCT4 Expression Is Deregulated in Cervical Cancer and Precursor Lesions.
    J Histochem Cytochem. 2022 May 26:221554221101662.
    PubMed    
    Abstract available

  292. WANG YT, Li B
    [Research progress of sentinel lymph node biopsy technique in cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2022;44:377-381.
    PubMed    
    Abstract available

  293. MORADI S
    High effectiveness of papillomavirus vaccination in preventing cervical cancer: is not it time for low-income and middle-income countries to reap the benefits?
    Evid Based Nurs. 2022 May 25. pii: ebnurs-2022-103513.
    PubMed    


  294. CHIYODA T, Yoshihara K, Kagabu M, Nagase S, et al
    Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis.
    Int J Clin Oncol. 2022 May 25. pii: 10.1007/s10147-022-02178.
    PubMed    
    Abstract available

  295. BIZZARRI N, Loverro M, Angeles MA, Pedone Anchora L, et al
    Laparoscopic Ovarian Transposition with Extraperitonealization of the Infundibulopelvic Ligament for Cervical Cancer in Ten Steps.
    Ann Surg Oncol. 2022 May 24. pii: 10.1245/s10434-022-11870.
    PubMed    
    Abstract available

  296. WORMALD BW, Moser N, deSouza NM, Mantikas KT, et al
    Lab-on-chip assay of tumour markers and human papilloma virus for cervical cancer detection at the point-of-care.
    Sci Rep. 2022;12:8750.
    PubMed    
    Abstract available

  297. YAN X, Zhang S, Jia J, Yang J, et al
    Exosomal MiR-423-3p inhibits macrophage M2 polarization to suppress the malignant progression of cervical cancer.
    Pathol Res Pract. 2022;235:153882.
    PubMed    
    Abstract available

  298. WANG L, Ye G, Wang Y, Wang C, et al
    Stearoyl-CoA desaturase 1 regulates malignant progression of cervical cancer cells.
    Bioengineered. 2022;13:12941-12954.
    PubMed    
    Abstract available

  299. LI S, Zhang H, Jiao Y, Song X, et al
    Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2).
    Bioengineered. 2022;13:12912-12926.
    PubMed    
    Abstract available

  300. ALARCON-ROMERO LDC, Organista-Nava J, Gomez-Gomez Y, Ortiz-Ortiz J, et al
    Prevalence and Distribution of Human Papillomavirus Genotypes (1997-2019) and Their Association With Cervical Cancer and Precursor Lesions in Women From Southern Mexico.
    Cancer Control. 2022;29:10732748221103331.
    PubMed    
    Abstract available


  301. The Role of Calgranulin B Gene on the Biological Behavior of Squamous Cervical Cancer in vitro and in vivo [Retraction].
    Cancer Manag Res. 2022;14:1741-1742.
    PubMed    
    Abstract available

  302. QABBUS MB, Hunt KS, Dynka J, Woodworth CD, et al
    Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media.
    Toxicol Appl Pharmacol. 2022 May 20:116073. doi: 10.1016/j.taap.2022.116073.
    PubMed    
    Abstract available

  303. RAO Z, Shen J, Wang J, Zhang Z, et al
    The role of PICT1 in RPL11/Mdm2/p53 pathway-regulated inhibition of cell growth induced by topoisomerase IIalpha inhibitor against cervical cancer cell line.
    Biochem Pharmacol. 2022 May 20:115098. doi: 10.1016/j.bcp.2022.115098.
    PubMed    
    Abstract available

  304. YANG Y, Wang N, Shi X, Wang Y, et al
    Construction of an immune infiltration landscape based on immune-related genes in cervical cancer.
    Comput Biol Med. 2022;146:105638.
    PubMed    
    Abstract available

  305. JIANG X, Song J, Duan S, Cheng W, et al
    MRI radiomics combined with clinicopathologic features to predict disease-free survival in patients with early-stage cervical cancer.
    Br J Radiol. 2022 May 23:20211229. doi: 10.1259/bjr.20211229.
    PubMed    
    Abstract available

  306. GAO YH, Yu L, Liu ZS, Li YF, et al
    Correction to: Human papillomavirus drove cervical cancer: a study of the therapeutic potential of the combination of interferon with zinc.
    Mol Cell Biochem. 2022 May 23. pii: 10.1007/s11010-022-04453.
    PubMed    


  307. SARI ER, Adi-Kusumo F, Aryati L
    Mathematical analysis of a SIPC age-structured model of cervical cancer.
    Math Biosci Eng. 2022;19:6013-6039.
    PubMed    
    Abstract available

  308. ORELLANA T, Ross M, Dressen M, Beriwal S, et al
    Rare presentation of metastatic cervical cancer to the right upper extremity skeletal muscle and gluteal adipose tissue.
    Radiol Case Rep. 2022;17:2554-2558.
    PubMed    
    Abstract available

  309. ABEBAW E, Tesfa M, Gezimu W, Bekele F, et al
    Female healthcare providers' knowledge, attitude, and practice towards cervical cancer screening and associated factors in public hospitals of Northwest Ethiopia.
    SAGE Open Med. 2022;10:20503121221095931.
    PubMed    
    Abstract available

  310. NARDANGELI A, Autorino R, Boldrini L, Campitelli M, et al
    Neoadjuvant Chemoradiotherapy With Simultaneous Integrated Boost in Locally Advanced Cervical Cancer: Long Term Results of a Single-Center Experience.
    Front Oncol. 2022;12:883965.
    PubMed    
    Abstract available

  311. THEOFANAKIS C, Koulakmanidis AM, Prodromidou A, Haidopoulos D, et al
    Fertility-Sparing Treatment for Young Patients with Early-Stage Cervical Cancer: A Dawn of a New Era.
    Front Surg. 2022;9:867993.
    PubMed    


  312. LOVELL DY, Naumann RW
    The benefits of laparoscopic radical hysterectomy for cervical cancer: Res ipsa loquitur?
    J Minim Invasive Gynecol. 2022 May 19. pii: S1553-4650(22)00203.
    PubMed    
    Abstract available

  313. MING Y, Dong X, Zhao J, Chen Z, et al
    Deep learning-based multimodal image analysis for cervical cancer detection.
    Methods. 2022 May 19. pii: S1046-2023(22)00118.
    PubMed    
    Abstract available

  314. SASIENI P, Castanon A
    HPV vaccination and cervical cancer screening - Authors' reply.
    Lancet. 2022;399:1940.
    PubMed    


  315. BEWLEY S
    HPV vaccination and cervical cancer screening.
    Lancet. 2022;399:1939.
    PubMed    


  316. KAMAMOTO S, Murayama A, Hamaki T, Kusumi E, et al
    HPV vaccination and cervical cancer screening.
    Lancet. 2022;399:1939-1940.
    PubMed    


  317. DU Q, Liu P, Zhang C, Liu T, et al
    FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis.
    Cell Death Dis. 2022;13:488.
    PubMed    
    Abstract available

  318. JOH S, Violette CJ, Khetan VU, Tavakoli A, et al
    Metastatic extent-specific prognosis of women with stage IVB cervical cancer: multiple versus single distant organ involvement.
    Arch Gynecol Obstet. 2022 May 21. pii: 10.1007/s00404-022-06611.
    PubMed    
    Abstract available

  319. ZHU T, Cen Y, Chen Z, Zhang Y, et al
    Oncogenic circTICRR suppresses autophagy via binding to HuR protein and stabilizing GLUD1 mRNA in cervical cancer.
    Cell Death Dis. 2022;13:479.
    PubMed    
    Abstract available

  320. GEMER O, Namazov A, Ben-Arie A, Eitan R, et al
    Predicting the rate of adjuvant postoperative chemo/radiation in cervical cancer with tumor size >/=2 cm and <4 cm: An Israeli Gynecologic Oncology Group study.
    Surg Oncol. 2022 Apr 23:101777. doi: 10.1016/j.suronc.2022.101777.
    PubMed    
    Abstract available

  321. CHEN WC, Ngan HY, Yang LY, Chang WY, et al
    Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study.
    Taiwan J Obstet Gynecol. 2022;61:494-500.
    PubMed    
    Abstract available

  322. BEJAR FG, Oaknin A, Williamson C, Mayadev J, et al
    Novel Therapies in Gynecologic Cancer.
    Am Soc Clin Oncol Educ Book. 2022;42:1-17.
    PubMed    
    Abstract available

  323. CHEN W, Shen W, Gao L, Li X, et al
    Hybrid Loss-Constrained Lightweight Convolutional Neural Networks for Cervical Cell Classification.
    Sensors (Basel). 2022;22.
    PubMed    
    Abstract available

  324. MARTIN-VALLEJO J, Laforga JB, Molina-Bellido P, Clemente-Perez PA, et al
    Superficial spreading cervical squamous cell carcinoma in situ involving the endometrium: a case report and review of the literature.
    J Med Case Rep. 2022;16:196.
    PubMed    
    Abstract available

  325. YUAN MW, Wang HH, Duan RF, Xu KP, et al
    [Analysis on cancer incidence and mortality attributed to human papillomavirus infection in China, 2016].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43:702-708.
    PubMed    
    Abstract available

  326. RAMATLHO P, Grover S, Mathoma A, Tawe L, et al
    Human papillomavirus prevalence among unvaccinated young female college students in Botswana: A cross-sectional study.
    S Afr Med J. 2022;112:335-340.
    PubMed    
    Abstract available

  327. ROSE MM, Dhamodharan S, Revathidevi S, Chakkarappan SR, et al
    High incidence of PI3K pathway gene mutations in South Indian cervical cancers.
    Cancer Genet. 2022;264-265:100-108.
    PubMed    
    Abstract available

  328. MURAKAMI N, Ando K, Murata M, Murata K, et al
    An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma.
    J Radiat Res. 2022;63:412-427.
    PubMed    
    Abstract available

  329. MURAKAMI N, Ohno T, Toita T, Ando K, et al
    Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers.
    J Radiat Res. 2022;63:402-411.
    PubMed    
    Abstract available

  330. WANG H, Tsai YH, Dong YH, Liu JJ, et al
    Young adult cancer incidence trends in Taiwan and the U.S. from 2002 to 2016.
    Cancer Epidemiol. 2022;78:102144.
    PubMed    
    Abstract available

  331. DURSUN F, Elshabrawy A, Wang H, Rodriguez R, et al
    Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma.
    Int J Clin Oncol. 2022;27:1068-1076.
    PubMed    
    Abstract available

  332. LORENSET LC, Zanine RM
    Reliability of negative cone specimens of the cervix: A review.
    Ann Diagn Pathol. 2022;58:151929.
    PubMed    
    Abstract available

  333. FORNAGE S, Schweizer A, Lepigeon K, Bianchi Demicheli F, et al
    Is women's sexual function impaired by an abnormal pap smear?
    Eur J Contracept Reprod Health Care. 2022;27:184-188.
    PubMed    
    Abstract available

  334. GILBERT L, Ratnam S, Jang D, Alaghehbandan R, et al
    Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study.
    Cancer Biomark. 2022;34:347-358.
    PubMed    
    Abstract available

  335. PULKKINEN J, Huhtala H, Krogerus LA, Hollmen S, et al
    Endocervical Cytology: Inter- and Intra-Observer Variability in Conventional Pap Smears.
    Acta Cytol. 2022;66:206-215.
    PubMed    
    Abstract available

  336. BONEFELD RE, Poulsgaard Frandsen A, Christensen J, Larsen T, et al
    A walk-in clinic as an alternative approach to reaching non-attenders of the cervical cancer screening program in the North Denmark region-a pilot study.
    Acta Obstet Gynecol Scand. 2022 May 11. doi: 10.1111/aogs.14377.
    PubMed    
    Abstract available

  337. STOLNICU S, Karpathiou G, Guerra E, Mateoiu C, et al
    Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases.
    Am J Surg Pathol. 2022;46:765-773.
    PubMed    
    Abstract available

  338. O'ROURKE K
    Cemiplimab shines for recurrent cervical cancer.
    Cancer. 2022;128:2050-2051.
    PubMed    


  339. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed    
    Abstract available

  340. STENZEL AE, Bustamante G, Sarkin CA, Harripersaud K, et al
    The intersection of sexual orientation with race and ethnicity in cervical cancer screening.
    Cancer. 2022 May 16. doi: 10.1002/cncr.34213.
    PubMed    
    Abstract available

  341. VIOLETTE CJ, Mandelbaum RS, Bainvoll L, Joh S, et al
    Trends and characteristics of ovarian conservation at hysterectomy for young women with cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2022;273:59-64.
    PubMed    
    Abstract available

  342. POTHURI B, Eskander RN, Randall LM, O'Malley DM, et al
    Practice changing cervical cancer clinical trials.
    Gynecol Oncol. 2022 Apr 20. pii: S0090-8258(22)00175.
    PubMed    


  343. POLTERAUER S, Reich O, Widschwendter A, Hadjari L, et al
    Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
    Gynecol Oncol. 2022;165:23-29.
    PubMed    
    Abstract available

  344. LIAO X, Xia X, Su W, Yan H, et al
    Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
    Gynecol Oncol. 2022;165:105-113.
    PubMed    
    Abstract available

  345. KASHOFER K, Regauer S, Reich O, Petru E, et al
    Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
    Gynecol Oncol. 2022;165:121-128.
    PubMed    
    Abstract available

  346. WANG J, Dong J, Zhou Y, Wang K, et al
    Performance of human papillomavirus (HPV) mRNA testing and HPV 16 and 18/45 genotyping combined with age stratification in the triaging of women with ASC-US cytology.
    Gynecol Oncol. 2022 Jan 4. pii: S0090-8258(21)01701.
    PubMed    
    Abstract available

  347. CORRIGAN KL, Yoder A, De B, Lin L, et al
    Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.
    Gynecol Oncol. 2021 Dec 30. pii: S0090-8258(21)01690.
    PubMed    
    Abstract available

  348. THOMAS RJ, Provenzano D, Goyal S, Loew M, et al
    Trends in guideline-adherent chemoradiation therapy for locally advanced cervical cancer before and after the affordable care act.
    Gynecol Oncol. 2022 Apr 28. pii: S0090-8258(22)00256.
    PubMed    
    Abstract available

  349. XU JY, Chen JN, Lei J, Hu M, et al
    Local treatment improves survival in patients with stage IVB cervical cancer.
    Gynecol Oncol. 2022 Apr 27. pii: S0090-8258(22)00254.
    PubMed    
    Abstract available

  350. TANIGAWA T, Takeshima N, Ishikawa H, Nishio S, et al
    Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
    Gynecol Oncol. 2022 Apr 26. pii: S0090-8258(22)00252.
    PubMed    
    Abstract available

  351. KIM SK, Ursell P, Coleman RL, Monk BJ, et al
    Mitigation and management strategies for ocular events associated with tisotumab vedotin.
    Gynecol Oncol. 2022;165:385-392.
    PubMed    
    Abstract available

  352. GOINS EC, Weber JM, Truong T, Moss HA, et al
    Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database.
    Gynecol Oncol. 2022 Feb 28. pii: S0090-8258(22)00069.
    PubMed    
    Abstract available

  353. KOBAYASHI E, Nakatani E, Tanaka T, Yosuke K, et al
    Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081.
    Gynecol Oncol. 2022 Feb 24. pii: S0090-8258(22)00089.
    PubMed    
    Abstract available

  354. ALGERA MD, van Driel WJ, Slangen BFM, Kruitwagen RFPM, et al
    Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the 'Dutch Gynecological Oncology Audit'.
    Gynecol Oncol. 2022 Feb 22. pii: S0090-8258(22)00123.
    PubMed    
    Abstract available

  355. MCKINNISH TR, Greenwade MM, Wilkinson-Ryan I, Schwarz JK, et al
    Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography.
    Gynecol Oncol. 2022 May 7. pii: S0090-8258(22)00259.
    PubMed    
    Abstract available

  356. RONSINI C, Kohler C, De Franciscis P, La Verde M, et al
    Laparo-assisted vaginal radical hysterectomy as a safe option for Minimal Invasive Surgery in early stage cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 May 2. pii: S0090-8258(22)00251.
    PubMed    
    Abstract available

  357. ZHOU S, Liu S, Tian G, Zhao L, et al
    KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer.
    Gynecol Oncol. 2022 May 17. pii: S0090-8258(22)00309.
    PubMed    
    Abstract available

  358. MARTIN AL, Sinha S, Peres LC, Hakam A, et al
    The impact of distance to closest negative margin on survival after pelvic exenteration.
    Gynecol Oncol. 2022;165:514-521.
    PubMed    
    Abstract available

  359. LUHRS O, Bollino M, Ekdahl L, Lonnerfors C, et al
    Similar distribution of pelvic sentinel lymph nodes and nodal metastases in cervical and endometrial cancer. A prospective study based on lymphatic anatomy.
    Gynecol Oncol. 2022 Apr 15. pii: S0090-8258(22)00209.
    PubMed    
    Abstract available

  360. SAND FL, Frederiksen K, Kjaer SK
    Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins.
    Gynecol Oncol. 2022 Apr 7. pii: S0090-8258(22)00197.
    PubMed    
    Abstract available

  361. SALVO G, Jhingran A, Ramalingam P, Legarreta AF, et al
    Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study.
    Gynecol Oncol. 2022 Apr 5. pii: S0090-8258(22)00204.
    PubMed    
    Abstract available

  362. GOTTSCHLICH A, Gondara L, Smith LW, Cook D, et al
    HPV-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV FOr CervicAL Cancer (HPV FOCAL) trial.
    Int J Cancer. 2022 Apr 22. doi: 10.1002/ijc.34039.
    PubMed    
    Abstract available

  363. HURTADO-SALGADO E, Cardenas-Cardenas L, Salmeron J, Luna-Gordillo R, et al
    Comparative performance of the human papillomavirus test and cytology for primary screening for high-grade cervical intraepithelial neoplasia at the population level.
    Int J Cancer. 2022;150:1422-1430.
    PubMed    
    Abstract available

  364. THIANGPHAK E, Pruegsanusak K, Buhachat R
    Pretreatment lymphocyte count as independent prognostic factor in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Int J Gynaecol Obstet. 2022 Apr 23. doi: 10.1002/ijgo.14229.
    PubMed    
    Abstract available

  365. FRICK A, Azuaga A, Abdulcadir J
    Cervical dysplasia among migrant women with female genital mutilation/cutting type III: A cross-sectional study.
    Int J Gynaecol Obstet. 2022;157:557-563.
    PubMed    
    Abstract available

  366. OLTHOF EP, Wenzel H, van der Velden J, Spijkerboer AM, et al
    Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.
    Int J Gynecol Cancer. 2022 Apr 28. pii: ijgc-2022-003357.
    PubMed    
    Abstract available

  367. SANSON C, Zaccarini F, Majer M, Pautier P, et al
    Neoadjuvant chemotherapy in fertility-sparing management of FIGO 2018 stage IB2 cervical cancer.
    Int J Gynecol Cancer. 2022;32:680-685.
    PubMed    


  368. BHATIA R, Graham C, Elasifer H, Asodaria P, et al
    Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.
    J Clin Virol. 2022;150-151:105165.
    PubMed    
    Abstract available

  369. GOGOI RP, Wallbillich JJ, Winer I, Morris R, et al
    Computer-Animated Relational Agents in Human Papillomavirus Vaccination Education.
    Obstet Gynecol. 2022;139:913-915.
    PubMed    


  370. LYCKE KD, Petersen LK, Gravitt PE, Hammer A, et al
    Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2.
    Obstet Gynecol. 2022;139:680-686.
    PubMed    
    Abstract available

  371. HANDE V, Chopra S, Kalra B, Abdel-Wahab M, et al
    Point-A vs. volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis.
    Radiother Oncol. 2022;170:70-78.
    PubMed    
    Abstract available

  372. HEMMINKI K, Kanerva A, Forsti A, Hemminki A, et al
    Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.
    BMC Cancer. 2022;22:456.
    PubMed    
    Abstract available

  373. CHEN R, Gan Q, Zhao S, Zhang D, et al
    DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
    BMC Cancer. 2022;22:488.
    PubMed    
    Abstract available

  374. BENIDER A, Bendahhou K, Sauvaget C, Mrabti H, et al
    Evolution of patterns of care for women with cervical cancer in Morocco over a decade.
    BMC Cancer. 2022;22:479.
    PubMed    
    Abstract available

  375. CAO HZ, Yang WT, Zheng PS
    Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
    BMC Cancer. 2022;22:521.
    PubMed    
    Abstract available

  376. JUDAH G, Dilib F, Darzi A, Huf S, et al
    A population survey on beliefs around cervical cancer screening: determining the barriers and facilitators associated with attendance.
    BMC Cancer. 2022;22:522.
    PubMed    
    Abstract available

  377. DENG ZM, Chen GH, Dai FF, Liu SY, et al
    The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets.
    PLoS One. 2022;17:e0267108.
    PubMed    
    Abstract available

  378. TEKALIGN T, Teshome M
    Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis.
    PLoS One. 2022;17:e0267571.
    PubMed    
    Abstract available

  379. ELIES A, Bonneau C, Houzard S, Rouzier R, et al
    Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.
    PLoS One. 2022;17:e0264821.
    PubMed    
    Abstract available

  380. MBULAWA ZZA, Phohlo K, Garcia-Jardon M, Williamson AL, et al
    High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
    PLoS One. 2022;17:e0264498.
    PubMed    
    Abstract available

  381. TAYLOR MM, Wi T, Gerbase A, Thwin SS, et al
    Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021).
    PLoS One. 2022;17:e0263550.
    PubMed    
    Abstract available

  382. DUFEIL E, Kenfack B, Tincho E, Fouogue J, et al
    Addition of digital VIA/VILI to conventional naked-eye examination for triage of HPV-positive women: A study conducted in a low-resource setting.
    PLoS One. 2022;17:e0268015.
    PubMed    
    Abstract available

  383. WINARTO H, Habiburrahman M, Dorothea M, Wijaya A, et al
    Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.
    PLoS One. 2022;17:e0266139.
    PubMed    
    Abstract available

  384. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
    Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
    PLoS One. 2022;17:e0265881.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;